Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Harleen K. Sidhu"'
Autor:
Huaibin M. Ko, Juan C. Hernandez-Prera, Hongfa Zhu, Steven H. Dikman, Harleen K. Sidhu, Stephen C. Ward, Swan N. Thung
Publikováno v:
Clinical and Developmental Immunology, Vol 2012 (2012)
Cirrhosis and hepatocellular carcinoma are the prototypic complications of chronic hepatitis C virus infection in the liver. However, hepatitis C virus also affects a variety of other organs that may lead to significant morbidity and mortality. Extra
Externí odkaz:
https://doaj.org/article/0737c81bd32a47aab16fc4f734dc5af7
Autor:
Harleen K. Sidhu, Philip Friedlander, Rui Chang, Shaily Shah, Michael Pan, Marina Moskalenko, Serge Sicular, Yvonne M. Saenger, Sebastian Bernardo, Sara Harcharik
Publikováno v:
Melanoma Research. 23:47-54
Melanoma is the deadliest form of skin cancer. Ipilimumab, a novel immunotherapy, is the first treatment shown to improve survival in patients with metastatic melanoma in large randomized controlled studies. The most concerning side effects reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a781ebf016139d42029a744e20d0595
https://doi.org/10.1097/cmr.0b013e32835c7e68
https://doi.org/10.1097/cmr.0b013e32835c7e68
Publikováno v:
Melanoma research. 23(6)
Sweet's syndrome, a neutrophilic dermatosis, is a known paraneoplastic complication occurring with various malignancies. It has been infrequently reported in association with melanoma. Ipilimumab is an antibody against an inhibitory cytotoxic T-lymph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e5b4377d5a9623715cdf7e5396fd407
https://pubmed.ncbi.nlm.nih.gov/24113862
https://pubmed.ncbi.nlm.nih.gov/24113862
Publikováno v:
Dermatologic clinics. 30(4)
This article reviews the recent dermatopathology literature involving nonmelanocytic neoplasia, with a focus on important work done over the last 5 years. The discussion includes advances in the understanding of Merkel cell carcinoma pathogenesis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44b0de681c30e032916ad9bdd88a0b1d
https://pubmed.ncbi.nlm.nih.gov/23021050
https://pubmed.ncbi.nlm.nih.gov/23021050
Publikováno v:
International journal of surgical pathology. 18(5)
Enfuvirtide (ENF, T-20, or Fuzeon [Hoffman-La Roche Inc, Nutley, NJ, and Trimeris, Inc, Durham, NC]) is an HIV-1 fusion inhibitor and is the only injectable antiretroviral drug available. Injection site reactions (ISRs) are the most frequently report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6042d492e5adcc442a3406ea795944
https://pubmed.ncbi.nlm.nih.gov/19223380
https://pubmed.ncbi.nlm.nih.gov/19223380
Publikováno v:
American Journal of Clinical Pathology. 138:A349-A349
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f553d7d351bc96275c9886d1479bfe22
https://doi.org/10.1093/ajcp/138.suppl2.131
https://doi.org/10.1093/ajcp/138.suppl2.131